They are educational scenarios, not identifiable patients or guarantees of coverage
Shes very thoughtful, caring and critically honest
As we confront the obesity epidemic and the broader public health issues that come with it, we need Medicaid and other health plans to cover weight loss drugs in a way that is effective and affordable for patients and taxpayers
There will be a narrower range of qualifying comorbidities than in the Scottish guidance (hypertension, dyslipidaemia, obstructive sleep apnoea and cardiovascular disease, with type 2 diabetes qualifying as a comorbidity in later cohorts)
Important safety information : Semaglutide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
In September of 2023, the Food and Drug Administration (FDA) added an additional serious side-effect to the Ozempic labeling: Ileus
